Sensitivity analyses of the primary efficacy endpoint in a...

Sensitivity analyses of the primary efficacy endpoint in a randomized-withdrawal phase 3 trial of tapentadol extended release (ER) in patients with painful diabetic peripheral neuropathy (DPN)

Etropolski, M., Steup, A., Shapiro, D.Y., Okamoto, A., Haeussler, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Year:
2009
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/S1499-2671(09)33156-1
File:
PDF, 448 KB
english, 2009
Conversion to is in progress
Conversion to is failed